These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 16630992

  • 1. A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study.
    Kardys I, Klaver CC, Despriet DD, Bergen AA, Uitterlinden AG, Hofman A, Oostra BA, Van Duijn CM, de Jong PT, Witteman JC.
    J Am Coll Cardiol; 2006 Apr 18; 47(8):1568-75. PubMed ID: 16630992
    [Abstract] [Full Text] [Related]

  • 2. Usefulness of combining complement factor H and C-reactive protein genetic profiles for predicting myocardial infarction (from the Rotterdam Study).
    Kardys I, de Maat MP, Klaver CC, Despriet DD, Uitterlinden AG, Hofman A, de Jong PT, Witteman JC.
    Am J Cardiol; 2007 Aug 15; 100(4):646-8. PubMed ID: 17697822
    [Abstract] [Full Text] [Related]

  • 3. The common Y402H variant in complement factor H gene is not associated with susceptibility to myocardial infarction and its related risk factors.
    Stark K, Neureuther K, Sedlacek K, Hengstenberg W, Fischer M, Baessler A, Wiedmann S, Jeron A, Holmer S, Erdmann J, Schunkert H, Hengstenberg C.
    Clin Sci (Lond); 2007 Aug 15; 113(4):213-8. PubMed ID: 17472578
    [Abstract] [Full Text] [Related]

  • 4. Complement factor H (Y402H) polymorphism and risk of coronary heart disease in US men and women.
    Pai JK, Manson JE, Rexrode KM, Albert CM, Hunter DJ, Rimm EB.
    Eur Heart J; 2007 Jun 15; 28(11):1297-303. PubMed ID: 17483111
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: the Rotterdam Study.
    Sayed-Tabatabaei FA, Schut AF, Arias Vásquez A, Bertoli-Avella AM, Hofman A, Witteman JC, van Duijn CM.
    J Med Genet; 2005 Jan 15; 42(1):26-30. PubMed ID: 15635071
    [Abstract] [Full Text] [Related]

  • 6. Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia.
    Koeijvoets KC, Mooijaart SP, Dallinga-Thie GM, Defesche JC, Steyerberg EW, Westendorp RG, Kastelein JJ, van Hagen PM, Sijbrands EJ.
    Eur Heart J; 2009 Mar 15; 30(5):618-23. PubMed ID: 19098018
    [Abstract] [Full Text] [Related]

  • 7. Synergistic effect of thrombomodulin promoter -33G/A polymorphism and smoking on the onset of acute myocardial infarction.
    Li YH, Chen JH, Tsai WC, Chao TH, Guo HR, Tsai LM, Wu HL, Shi GY.
    Thromb Haemost; 2002 Jan 15; 87(1):86-91. PubMed ID: 11848462
    [Abstract] [Full Text] [Related]

  • 8. The cholesteryl ester transfer protein I405V polymorphism is associated with increased high-density lipoprotein levels and decreased risk of myocardial infarction: the Rotterdam Study.
    Isaacs A, Sayed-Tabatabaei FA, Hofman A, Oostra BA, Klungel OH, Maitland-Vander Zee AH, Stricker BH, Witteman JC, van Duijn CM.
    Eur J Cardiovasc Prev Rehabil; 2007 Jun 15; 14(3):419-21. PubMed ID: 17568242
    [Abstract] [Full Text] [Related]

  • 9. Complement factor H polymorphism in age-related macular degeneration.
    Narayanan R, Butani V, Boyer DS, Atilano SR, Resende GP, Kim DS, Chakrabarti S, Kuppermann BD, Khatibi N, Chwa M, Nesburn AB, Kenney MC.
    Ophthalmology; 2007 Jul 15; 114(7):1327-31. PubMed ID: 17306880
    [Abstract] [Full Text] [Related]

  • 10. Complement Factor H polymorphism Y402H associates with inflammation, visual acuity, and cardiovascular mortality in the elderly population at large.
    Mooijaart SP, Koeijvoets KM, Sijbrands EJ, Daha MR, Westendorp RG.
    Exp Gerontol; 2007 Nov 15; 42(11):1116-22. PubMed ID: 17869048
    [Abstract] [Full Text] [Related]

  • 11. [Classical risk factors for myocardial infarction and total mortality in the community--13-year follow-up of the MONICA Augsburg cohort study].
    Heidrich J, Wellmann J, Hense HW, Siebert E, Liese AD, Löwel H, Keil U.
    Z Kardiol; 2003 Jun 15; 92(6):445-54. PubMed ID: 12819993
    [Abstract] [Full Text] [Related]

  • 12. [A 20-year prospective study on risk factors for myocardial infarction of 5,137 men in Capital Steel and Iron Company].
    Yue H, Gu DF, Wu XG, Yu XH, Duan XF, Wang JH, Zheng RP, Zhou J.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Jan 15; 38(1):43-6. PubMed ID: 14989905
    [Abstract] [Full Text] [Related]

  • 13. Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged men.
    Ridker PM, Baker MT, Hennekens CH, Stampfer MJ, Vaughan DE.
    Arterioscler Thromb Vasc Biol; 1997 Sep 15; 17(9):1687-90. PubMed ID: 9327764
    [Abstract] [Full Text] [Related]

  • 14. Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients.
    Buraczynska M, Ksiazek P, Zukowski P, Benedyk-Lorens E, Orlowska-Kowalik G.
    Clin Immunol; 2009 Aug 15; 132(2):285-90. PubMed ID: 19428307
    [Abstract] [Full Text] [Related]

  • 15. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.
    Engström G, Hedblad B, Janzon L, Lindgärde F.
    Eur J Cardiovasc Prev Rehabil; 2007 Jun 15; 14(3):392-7. PubMed ID: 17568238
    [Abstract] [Full Text] [Related]

  • 16. Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus. The REGICOR Investigators.
    Aubó C, Sentí M, Marrugat J, Tomás M, Vila J, Sala J, Masiá R.
    Eur Heart J; 2000 Jan 15; 21(1):33-8. PubMed ID: 10610741
    [Abstract] [Full Text] [Related]

  • 17. Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease.
    Koch W, Hoppmann P, Mueller JC, Schömig A, Kastrati A.
    Arterioscler Thromb Vasc Biol; 2006 May 15; 26(5):1114-9. PubMed ID: 16543493
    [Abstract] [Full Text] [Related]

  • 18. Low complement C4B gene copy number predicts short-term mortality after acute myocardial infarction.
    Blaskó B, Kolka R, Thorbjornsdottir P, Sigurdarson ST, Sigurdsson G, Rónai Z, Sasvári-Székely M, Bödvarsson S, Thorgeirsson G, Prohászka Z, Kovács M, Füst G, Arason GJ.
    Int Immunol; 2008 Jan 15; 20(1):31-7. PubMed ID: 18032375
    [Abstract] [Full Text] [Related]

  • 19. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.
    Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M.
    N Engl J Med; 1998 Jul 23; 339(4):229-34. PubMed ID: 9673301
    [Abstract] [Full Text] [Related]

  • 20. Renal function and risk of myocardial infarction in an elderly population: the Rotterdam Study.
    Brugts JJ, Knetsch AM, Mattace-Raso FU, Hofman A, Witteman JC.
    Arch Intern Med; 1998 Jul 23; 165(22):2659-65. PubMed ID: 16344425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.